11 studies found for:    TPI | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
2 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
Interventions: Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
3 Recruiting A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TPI-287 2 mg/m2;   Drug: TPI-287 6.3 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo
4 Recruiting Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
Conditions: Brain Metastases;   Generalized Malignancy, Primary;   Brain Lesions
Interventions: Drug: TPI 287;   Procedure: Fractionated Stereotactic Radiotherapy (FSRT)
5 Recruiting Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain
Condition: Abdominal Pain
Interventions: Drug: Bupivacaine 0.25%;   Drug: Triamcinolone
6 Recruiting A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Condition: Advanced Solid Tumors
Intervention: Drug: TAS-102
7 Recruiting A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Condition: Advanced Solid Tumors
Intervention: Drug: TAS-102
8 Not yet recruiting Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
Conditions: Stroke;   Ischemic Attack, Transient
Interventions: Drug: Ticagrelor and Acetylsalicylic acid;   Drug: Clopidogrel and Acetylsalicylic acid
9 Unknown  Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution
Condition: Cystic Fibrosis
Intervention:
10 Not yet recruiting Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Conditions: Colon Cancer;   Rectal Cancer;   Liver Metastases
Interventions: Drug: Tas-102;   Device: SIR-Sphere
11 Recruiting Alvocidib Biomarker-driven Phase 2 AML Study
Condition: Acute Myeloid Leukemia
Interventions: Drug: Alvocidib;   Drug: Cytarabine;   Drug: Mitoxantrone

Indicates status has not been verified in more than two years